glp-1 drugs for weight loss reviews have taken the world by storm, helping many people lose 11%–16% of their body weight. But a new Cochrane review reveals something surprising: the evidence supporting these blockbuster injections isn't Side Effects of GLP-1 Diabetes

The duration of therapy with Semaglutide / Cyanocobalamin Injection varies considerably based on treatment indication, response, and individual patient factors

Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction

Han T, Wu Y, Han W, Yan K, Zhao J, Sun Y

Acute kidney injury (AKI) is a clinical syndrome that can arise from a variety of factors that produce a quick loss in renal function over a brief period

It says it plans to file an application for the drugs approval with the Food and Drug Administration (FDA) in the United States before the end of the year